Clinical significance of serum Wisteria floribunda agglutinin positive Mac‐2‐binding protein level and high‐sensitivity C‐reactive protein concentration in autoimmune hepatitis

We aimed to examine the relationship between the Wisteria floribunda agglutinin positive Mac‐2‐binding protein (WFA+‐M2BP) level and high‐sensitivity C‐reactive protein (hCRP) concentration and liver histological findings for patients with autoimmune hepatitis (AIH).

[1]  M. Shimizu,et al.  Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac‐2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  M. Kurosaki,et al.  Wisteria floribunda agglutinin positive human Mac‐2‐binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  J. Devière,et al.  Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease , 2015, European journal of gastroenterology & hepatology.

[4]  J. Jia,et al.  Autoimmune hepatitis: East meets west , 2015, Journal of gastroenterology and hepatology.

[5]  M. Karajeh,et al.  Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis , 2015, The American Journal of Gastroenterology.

[6]  A. Kuno,et al.  Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response , 2015, PloS one.

[7]  M. Lenzi,et al.  Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype , 2015, Alimentary pharmacology & therapeutics.

[8]  K. Koike,et al.  Slight elevation of high‐sensitivity C‐reactive protein to predict recurrence and survival in patients with early stage hepatitis C‐related hepatocellular carcinoma , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  M. Ota,et al.  Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis , 2015, The American Journal of Gastroenterology.

[10]  M. Manns,et al.  Autoimmune hepatitis--Update 2015. , 2015, Journal of hepatology.

[11]  A. Kuno,et al.  Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma , 2015, Journal of Gastroenterology.

[12]  Li-na Ma,et al.  Serum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis B. , 2015, Hepato-gastroenterology.

[13]  Lunan Yan,et al.  Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysis , 2015, Hepatology.

[14]  A. Lohse,et al.  Unmet clinical need in autoimmune liver diseases. , 2015, Journal of hepatology.

[15]  Y. Imai,et al.  Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease , 2015, Journal of Gastroenterology.

[16]  A. Kuno,et al.  Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients , 2014, Hepatology.

[17]  R. Malik,et al.  Noninvasive markers in the assessment and management of autoimmune liver diseases , 2014, European journal of gastroenterology & hepatology.

[18]  A. Czaja.  Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets , 2014, Alimentary pharmacology & therapeutics.

[19]  K. Higuchi,et al.  Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis , 2014, Journal of clinical biochemistry and nutrition.

[20]  A. Czaja.  Current and prospective pharmacotherapy for autoimmune hepatitis , 2014, Expert opinion on pharmacotherapy.

[21]  T. Chiba,et al.  Progression of autoimmune hepatitis is mediated by IL‐18‐producing dendritic cells and hepatic CXCL9 expression in mice , 2014, Hepatology.

[22]  M. Fritzler,et al.  Current Concepts and Future Directions for the Assessment of Autoantibodies to Cellular Antigens Referred to as Anti-Nuclear Antibodies , 2014, Journal of immunology research.

[23]  Kazuhide Yamamoto,et al.  Autoimmune hepatitis: Diagnosis and treatment guide in Japan, 2013 , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[24]  A. Czaja.  Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis , 2014, Alimentary pharmacology & therapeutics.

[25]  J. Neuberger,et al.  Autoimmune liver disease, autoimmunity and liver transplantation. , 2014, Journal of hepatology.

[26]  Y. Maehara,et al.  A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis , 2014, Journal of Gastroenterology.

[27]  A. Kuno,et al.  Reconstruction of a robust glycodiagnostic agent supported by multiple lectin‐assisted glycan profiling , 2013, Proteomics. Clinical applications.

[28]  Yoshiyuki Suzuki,et al.  Prognosis of autoimmune hepatitis showing acute presentation , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[29]  C. V. van Nieuwkerk,et al.  Auto immune hepatitis. , 2016, World journal of gastroenterology.

[30]  A. Kuno,et al.  A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis , 2013, Scientific Reports.

[31]  Kazuhide Yamamoto,et al.  Present status of autoimmune hepatitis in Japan: a nationwide survey , 2011, Journal of Gastroenterology.

[32]  Hirokazu Takahashi,et al.  High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH , 2007, Journal of Gastroenterology.

[33]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[34]  T. Arenovich,et al.  Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome , 2005, Hepatology.

[35]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[36]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[37]  K. Meyer zum Büschenfelde,et al.  Autoimmune hepatitis--an update. , 1992, Behring Institute Mitteilungen.